| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.23B | +6.3% |
| Cost of Revenue | $1.70B | +8.4% |
| Gross Profit | $1.53B | +4.0% |
| R&D Expense | $200.0M | +3.1% |
| SG&A Expense | $337.0M | -5.6% |
| Operating Income | $992.0M | +7.9% |
| Pre-tax Income | $897.0M | +8.5% |
| Income Tax | $166.0M | +7.8% |
| Net Income | $731.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $781.0M | +40.7% |
| Accounts Receivable | $360.0M | +1.1% |
| Inventory | $315.0M | +14.1% |
| Current Assets | $1.54B | +23.0% |
| Total Assets | $5.34B | +6.2% |
| Current Liabilities | $506.0M | +1.0% |
| Long-term Debt | $2.41B | -4.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $801.0M | +2.2% |
| Capital Expenditures | $143.0M | +14.4% |
| Investing Cash Flow | -$147.0M | -14.0% |
| Financing Cash Flow | -$427.0M | -28.6% |
| Free Cash Flow | $658.0M | -0.2% |
| +8.6% |
| EPS (Basic) | $8.40 | +12.3% |
| EPS (Diluted) | $8.31 | +12.3% |
| Total Liabilities |
| $3.69B |
| -2.8% |
| Stockholders' Equity | $1.65B | +33.9% |